Patients with Atrial Fibrillation are Unlikely to Benefit from Aspirin Monotherapy.

Nan WangQiqi HouShouling Wu Quanle Han Kangbo Li

Published in: International journal of general medicine (2024)

ASA monotherapy is not associated with a lower risk of ischemic events, while significantly associated with a higher risk of bleeding events. Patients with AF are unlikely to benefit from aspirin monotherapy.

Keyphrases

combination therapy
low dose
open label
atrial fibrillation
cardiovascular events
antiplatelet therapy
ischemia reperfusion injury
acute coronary syndrome
type diabetes
oxidative stress